Ahmed Farhath

Healthcare GRI Bio (NASDAQ:GRI) on Friday said its board approved a 1-for-7 reverse stock split of its common stock to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq. The reverse split will legally take effect at 4:01 p.m. Eastern Time on January 29, 2023. The company’s common stock will open for trading under a new CUSIP number 3622AW 205 on the Nasdaq on January 30, 2024, on a split-adjusted basis under the current ticker symbol “GRI.” The reverse split will reduce the number of shares of outstanding common stock from about 4,520,233 shares to about 645,736 shares. The total authorized number of shares will not be reduced. Press Release. Recommended For You More Trending News

57%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

85%

Examples:

  • Icahn disclosed that he bought JBLU shares in the belief that they were undervalued and represented an attractive investment opportunity
  • Jet Blue is unprofitable
  • the buyout made little sense

Conflicts of Interest

50%

Examples:

  • The article states that 'JetBlue stock soars after Icahn discloses stake', which implies a sudden increase in demand for JetBlue shares due solely to Icahn's investment. However, this is not supported by any evidence presented in the article and may be misleading.
  • The author presents Icahn's stake as a positive development for JetBlue when it is not clear if this will lead to any tangible benefits or improvements for the airline.

Contradictions

85%

Examples:

  • JetBlue's net loss was $153 million in the third quarter of 2023 and $104 million in the fourth quarter of 2023.

Deceptions

30%

Examples:

  • Healthcare GRI Bio (NASDAQ:GRI) on Friday said its board approved a 1-for-7 reverse stock split of its common stock to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq. The reverse split will legally take effect at 4:01 p.m. Eastern Time on January 29, 2023. The company’s common stock will open for trading under a new CUSIP number 3622AW 205 on the Nasdaq on January 30, 2024, on a split-adjusted basis under the current ticker symbol “GRI.” The reverse split will reduce the number of shares of outstanding common stock from about 4,520,233 shares to about 645,736 shares. The total authorized number of shares will not be reduced. Press Release. Recommended For You More Trending News
  • The article does not provide any information on the reasons or benefits of the reverse split and may be misleading to readers who are unaware of the financial situation of GRI Bio.

Recent Articles

JetBlue Airways Struggles to Return to Profitability as Activist Investor Carl Icahn Discloses Nearly 10% Stake in the Company

JetBlue Airways Struggles to Return to Profitability as Activist Investor Carl Icahn Discloses Nearly 10% Stake in the Company

Broke On: Tuesday, 13 February 2024 Activist investor Carl Icahn buys 10% stake in JetBlue, boosting its stock by 19%. The airline faces challenges such as a failed merger with Spirit and antitrust issues.